- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1484 |
Product Name |
ADT1484-Ozoralizumab Biosimilar-(ALB/TNFSF2/TNF-alpha/TNFA)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse ALB antibody, anti-ALB antibody, anti ALB antibody, recombinant ALB, ALB antibody, anti-ALB monoclonal antibody, ALB antibodies, ALB recombinant antibody, ALB blocking antibody, TNFSF2 recombinant antibody, TNFSF2 blocking antibody, TNF-alpha recombinant antibody, TNF-alpha blocking antibody, TNFA recombinant antibody, TNFA blocking antibody |
|
Alias |
ATN-103
|
Host |
CHO Cells |
Species |
Human |
Target |
TNF alpha/TNFA/ALB/TNFSF2 |
Gene ID |
7124 |
Isotype |
VH-VH'-VH |
Size |
1mg, 5mg |
Research Area |
Immunology |
CAS Number |
1167985-17-2 |
Product Description |
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm. |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Duan R, et al. Clin Appl Thromb Hemost, 2023 Jan-Dec. PMID 37229645
2. Wang A, et al. Med Mycol, 2023 Apr 3. PMID 37055372
3. Yoshii I. J Orthop Sci, 2023 May. PMID 36914483"
|